Iambic Prices $150 Million IPO at $16 a Share
Iambic’s October 14 pricing covers 9.375 million new shares at $16, with estimated net proceeds of $135 million. Scheduled trading and closing are not verified completion.
United States Capital Markets News
Capital-markets reporting focused on the United States.
US September Industrial Output Rises 0.7%
The Fed’s October 16 preliminary release reports monthly gains of 0.7% in industrial output and 0.3% in manufacturing. These seasonally adjusted measures are not GDP growth.
M&T Bank Q3 Profit Falls, but Reported EPS Rises to $5.04
M&T Bank’s Q3 net income fell to $775 million. Reported diluted EPS rose to $5.04; adjusted operating EPS was $5.08, a separate measure.
J.B. Hunt Q3 Revenue Rises 20%; Net Earnings Reach $172.4 Million
J.B. Hunt reported $3.68 billion of Q3 revenue and $172.4 million in net earnings. Revenue excluding fuel surcharges rose 13%, below the headline growth rate.
Prologis Q3 Earnings Rise as Full-Year Profit Guidance Falls
Prologis reported Q3 diluted EPS of $0.86 and non-GAAP Core FFO of $1.60 per share. It lowered its 2026 profit range while narrowing Core FFO guidance.
Nasdaq Shows October 14 Level Down 1.88%; October 15 Session Is Separate
Nasdaq’s official COMP page showed 26,692.87 points with an October 14 date and a 1.88% decline. It was not an October 15 cash-session reading; the next regular open was scheduled for 19:00 IST.
S&P 500’s October 14 Reading Falls 1.11% to 7,718.94 Points
S&P’s dated October 14 price-return reading was 7,718.94 points, down 1.11% for one day. Checked before the next US regular session, it is not an October 15 live quote.
Dow’s October 14 Reading at 51,621.48 Points, Down 0.09%
The Dow’s official October 14 USD Price Return reading was down 0.09% for one day. Its 11.56% one-year return is separate; this is not an October 15 live quote.
TRexBio Prices $116.7 Million IPO at $14 a Share
TRexBio priced 8,333,334 shares at $14, targeting $116.7 million in gross proceeds. October 9 trading and October 13 completion were expected, not confirmed here.
Moderna Joins Nasdaq-100 in October 9 Constituent Change
Nasdaq announced Moderna would replace Warner Bros. Discovery before October 9 trading. Its public start-of-day constituent list now includes MRNA.
Teradyne Adds Burn-In Testing to Titan HP for High-Power AI Chips
Teradyne says Titan HP’s enhanced burn-in is available and deployed in production. The practical change is per-device thermal stress and testing, not a verified savings figure.
Lamb Weston Raises Outlook as Quarterly Profit Falls 55%
Lamb Weston earnings show $1.67 billion in sales and a 55% fall in reported net profit. Its raised FY2027 outlook uses adjusted, non-GAAP measures.